Investor's Business Daily on MSN
IBD stock of the day: Ligand Pharma, biotech's royalty arm, breaks out
Ligand Pharmaceuticals is Tuesday's IBD Stock Of The Day. The biotech stock has blown past several buy points on its way to a new breakout.
New ECCO dietary therapy guidelines for IBD clarify the role of enteral nutrition, Mediterranean diet, supplements, and RD ...
Inflammatory bowel disease (IBD) is a chronic condition that currently does not have a cure. However, certain lifestyle measures, such as keeping an IBD journal, can help you track symptoms, identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results